Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2023-10-02 00:00:00 ET · period of report 2023-09-24 · accession 0001628280-23-033504 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-02 | 2023-09-24 | BLFS | Mathew Aby J. | EVP, CSO | A - Grant | — | +802 | 273.8K | +0.3% | — | |
| 2023-10-02 | 2023-09-28 | BLFS | Mathew Aby J. | EVP, CSO | S - Sale | $14.16 | -659 | 273.1K | -0.2% | -$9,331 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-24 | A | A | 802 | — | 273,780 | D | — | — | (F1) The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. |
| 2 | Common | Common Stock | 2023-09-28 | S | D | 659 | $14.16 | 273,121 | D | — | — |